Regulated cell death in hypoxic-ischaemic encephalopathy: recent development and mechanistic overview

Lingzhi Wu,Enqiang Chang,Hailin Zhao,Daqing Ma

DOI: https://doi.org/10.1038/s41420-024-02014-2

2024-06-12

Cell Death Discovery

Abstract:Hypoxic-ischaemic encephalopathy (HIE) in termed infants remains a significant cause of morbidity and mortality worldwide despite the introduction of therapeutic hypothermia. Depending on the cell type, cellular context, metabolic predisposition and insult severity, cell death in the injured immature brain can be highly heterogenous. A continuum of cell death exists in the H/I-injured immature brain. Aside from apoptosis, emerging evidence supports the pathological activation of necroptosis, pyroptosis and ferroptosis as alternative regulated cell death (RCD) in HIE to trigger neuroinflammation and metabolic disturbances in addition to cell loss. Upregulation of autophagy and mitophagy in HIE represents an intrinsic neuroprotective strategy. Molecular crosstalk between RCD pathways implies one RCD mechanism may compensate for the loss of function of another. Moreover, mitochondrion was identified as the signalling "hub" where different RCD pathways converge. The highly-orchestrated nature of RCD makes them promising therapeutic targets. Better understanding of RCD mechanisms and crosstalk between RCD subtypes likely shed light on novel therapy development for HIE. The identification of a potential RCD converging node may open up the opportunity for simultaneous and synergistic inhibition of cell death in the immature brain.

cell biology

What problem does this paper attempt to address?

The paper aims to explore the regulatory mechanisms of cell death in neonatal hypoxic-ischemic encephalopathy (HIE) and provides an overview of recent advances in this field. Specifically, the paper focuses on the following points:

1. **Diversity of Regulated Cell Death (RCD)**: In HIE, in addition to classical apoptosis, there are various forms of regulated cell death such as necroptosis, pyroptosis, and ferroptosis. These different RCD pathways may collectively promote cell loss through neuroinflammation and metabolic disturbances.

2. **Role of Autophagy and Mitophagy**: Under HIE conditions, autophagy and mitophagy are upregulated, which may represent an endogenous neuroprotective strategy.

3. **Molecular Interactions Between Different RCD Pathways**: There may be interactions between RCD mechanisms, where one RCD mechanism may compensate for the functional loss of another. Additionally, mitochondria are considered the signaling "hub" where different RCD pathways converge.

4. **Potential of RCD as Therapeutic Targets**: Due to the highly coordinated nature of RCD, they become potential therapeutic targets. A better understanding of RCD mechanisms and their interactions among subtypes may provide clues for the development of new therapies for HIE.

5. **Differences Between Mature and Developing Brains**: Current understanding of cell death mechanisms during hypoxic-ischemic brain injury mainly comes from studies on adult brains. More research is needed on developing, immature brains, as their unique vulnerability, plasticity, and regenerative capacity may lead to different injury mechanisms.

6. **Limitations of Clinical Research**: Human clinical research and evidence on HIE are very limited, and there is an urgent need to expand research efforts to enhance the translatability of mechanistic insights gained from animal studies.

In summary, this review paper attempts to provide a theoretical basis for the future development of new therapeutic approaches through an in-depth analysis of the regulatory mechanisms of cell death in HIE.